Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/143770| Title: | Cytoreductive surgery for advanced tubo-ovarian cancer : a paradigm shift |
| Authors: | Brincat, Mark |
| Keywords: | Cytoreduction surgical procedures Ovaries -- Cancer -- Surgery Ovarian neoplasms Oncology |
| Issue Date: | 2024 |
| Publisher: | Malta Leadership Institute (MLI) |
| Citation: | Brincat, M. (2024). Cytoreductive surgery for advanced tubo-ovarian cancer : a paradigm shift. The Synapse : the Medical Professionals' Network, 23(2), 6-10. |
| Abstract: | Complete macroscopic cytoreduction is the best prognostic variable a patient could experience during treatment for advanced ovarian cancer. Malta needs to make great strides to satisfy European-standard quality indicators for surgical management of advanced gynaecological cancer, and to progress toward 5-year survival rates of neighbouring countries. Surgical cytoreductive management requires a dedicated centralised team that can provide subspecialised multidisciplinary care. This article provides an overview of the role of cytoreductive surgery along the disease trajectory of advanced tubo-ovarian cancer. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/143770 |
| Appears in Collections: | The Synapse, Volume 23, Issue 2 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| TheSynapse23(2)A1.pdf | 2.86 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.